Why is P & G Health Ltd falling/rising?

As of 18-Sep, Procter & Gamble Health Ltd's stock is currently priced at 6,251.20, reflecting a decrease of 78.8 points or 1.24%. The stock has underperformed its sector today by 2.29% and has experienced a consecutive decline over the last two days, resulting in a total drop of 1.36% during this period. Despite a strong year-to-date performance of 19.52% and a one-year return of 21.93%, the stock's recent movement is influenced by its higher trading volumes, which have increased by 45.31% against the five-day average, indicating rising investor participation. However, the stock's long-term growth prospects appear limited, as evidenced by its net sales growth of only 7.39% annually over the last five years and a high valuation reflected in its price-to-book ratio of 19.3.
In the broader market context, the stock's short-term performance has lagged behind the Sensex, which has gained 1.80% over the past week, while Procter & Gamble Health Ltd has declined by 1.72%. This underperformance in the short term contrasts with its strong long-term returns, suggesting that while the company has shown resilience and positive results in recent quarters, investor sentiment may be tempered by concerns over its growth rate and valuation. The overall market has also faced challenges, with the BSE500 generating negative returns of -1.96% in the last year, yet Procter & Gamble Health Ltd has managed to outperform this benchmark significantly.